Helius Medical Technologies Inc (NASDAQ: HSDT) Stock In Prove Me State

Helius Medical Technologies Inc (HSDT) concluded trading on Wednesday at a closing price of $6.48, with 5.7 million shares of worth about $36.95 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -33.33% during that period and on April 3, 2024 the price saw a gain of about 14.49%. Currently the company’s common shares owned by public are about 0.89M shares, out of which, 0.85M shares are available for trading.

Stock saw a price change of 16.13% in past 5 days and over the past one month there was a price change of 11.72%. Year-to-date (YTD), HSDT shares are showing a performance of -19.39% which decreased to -49.14% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $4.29 but also hit the highest price of $14.44 during that period. The average intraday trading volume for Helius Medical Technologies Inc shares is 310.70K. The stock is currently trading 12.54% above its 20-day simple moving average (SMA20), while that difference is up 7.77% for SMA50 and it goes to -14.99% lower than SMA200.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Helius Medical Technologies Inc (NASDAQ: HSDT) currently have 0.89M outstanding shares and institutions hold larger chunk of about 7.82% of that.

The stock has a current market capitalization of $5.77M and its 3Y-monthly beta is at 1.54. It has posted earnings per share of -$14.30 in the same period. It has Quick Ratio of 3.64 while making debt-to-equity ratio of 0.03. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for HSDT, volatility over the week remained 8.11% while standing at 6.78% over the month.

Analysts are in expectations that Helius Medical Technologies Inc (HSDT) stock would likely to be making an EPS of -$3.41 in the current quarter, while forecast for next quarter EPS is -$2.03 and it is -$4.42 for next year. For the current quarter EPS, analysts have given the company a lowest target -$5.04 which is -$2.49 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$4.5 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 27.85% while it is estimated to increase by 48.07% in next year.

Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Noble Capital Markets on March 24, 2021 offering an Outperform rating for the stock and assigned a target price of $20 to it.

Most Popular

Related Posts